Aberrant expression of miRNAs correlates with the development and progression of tumors; inhibition of their expression can modulate the cancer phenotype, suggesting their potential as anticancer drug targets.
Aberrant DNA methylation patterns have been associated with a large number of human malignancies and found in two distinct forms: hypermethylation and hypomethylation compared to normal tissue.
